Actively Recruiting
Antibacterial Photodynamic Therapy as an Adjunctive Treatment on Oral Hygiene in Elderly Persons
Led by Koite Health Oy · Updated on 2025-08-07
100
Participants Needed
3
Research Sites
125 weeks
Total Duration
On this page
Sponsors
K
Koite Health Oy
Lead Sponsor
U
University of Helsinki
Collaborating Sponsor
AI-Summary
What this Trial Is About
On average, the dental condition of elderly people is poor due to various reasons. The importance of oral health maintenance of the ageing population has been recognized by the World Health Organization (WHO), as oral health plays a key role in reaching the global goal of the "Decade of Healthy Ageing 2021-2030". New measures for maintaining good oral health are welcome. The use of antibacterial photodynamic therapy (aPDT) and antibacterial blue light (aBL) has been studied and found to reduce the amount of plaque in the mouth. The Lumoral device is a CE-marked home medical device combining aPDT and aBL, and it is effective in reducing the development of plaque and harmful bacteria in the plaque. The device has also been shown to be easy and safe to use. In this study, a combination of regular dental appointments with the importance of enhanced dental self-care, will be tested as one regional solution for reaching the global goal set by WHO.
CONDITIONS
Official Title
Antibacterial Photodynamic Therapy as an Adjunctive Treatment on Oral Hygiene in Elderly Persons
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Elderly person aged 65 years or older living at home or in a care home with access to regular dental care appointments
- Ability to understand and sign informed consent
- Having at least 10 teeth in the mouth, including implants
- Ability to understand and follow the study protocol, including tooth brushing and using the Lumoral Treatment, as assessed by the investigator
You will not qualify if you...
- Uncontrolled diabetes mellitus
- Severe dementia or similar conditions limiting understanding of study information and protocol
- Physical limitations restricting use of the Lumoral device
- Current active smoking or use of other tobacco products
- Use of antibiotics within 4 weeks prior to the study
- Presence of oral thrush
- Known sensitivity to near-infrared or antibacterial blue light
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
SuperSuu
Loviisa, Uusimaa, Finland, 07900
Actively Recruiting
2
SuperSuu
Sipoo, Uusimaa, Finland, 04130
Actively Recruiting
3
KotiHammas
Vantaa, Uusimaa, Finland, 01600
Actively Recruiting
Research Team
M
Mikko Kylmänen, Master of Health Care
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here